SkyQuest Technology Group recently introduced Genetic Toxicology Testing Market study with in-depth overview, describing about the Product/Industry Scope and elaborates market outlook and status (2025-2032). Genetic toxicology testing is a critical component of the broader pharmaceutical, biotechnology, and chemical industries. Genetic toxicology testing is a vital phase in the safety assessment of new drugs, chemicals, and consumer products, ensuring their potential risks to human health and the environment are thoroughly evaluated.
Genetic Toxicology Testing Market size was valued at USD 1.56 billion in 2023 and is poised to grow from USD 1.60 billion in 2024 to USD 2.82 billion by 2032, growing at a CAGR of 7.3% during the forecast period (2025-2032).
This market’s overview reflects its growing significance due to increasing regulatory scrutiny, advancements in testing methods, and a heightened emphasis on public health and safety. The market is experiencing notable growth due to factors such as expanding pharmaceutical and chemical R&D activities, stringent regulations set by global health authorities, and a rising awareness of the potential long-term effects of exposure to genotoxic substances.
Get a Free Sample PDF of the Report – https://www.skyquestt.com/sample-request/genetic-toxicology-testing-market
The 2025 global Genetic Toxicology Testing Market report provides a comprehensive analysis of key industry players, market trends, pricing structures, and competitive dynamics, offering insights into the market landscape from 2025 to 2032. As a rapidly evolving sector, the Genetic Toxicology Testing Market drives economic growth, innovation, and technological advancements through the development, production, and distribution of products and services. This report highlights the market’s growth potential and its impact on global industries, providing valuable insights for stakeholders, investors, and policymakers.
Detailed Segmentation and Classification of the report (Market Size and Forecast – 2032, Y-o-Y growth rate, and CAGR):
The Genetic Toxicology Testing Market can be segmented based on several factors, including product type, application, end-user, and distribution channel.
Global Genetic Toxicology Testing Market is segmented by Testing Methodology, Product, Assay Type, End User and region.
Based on Testing Methodology, the market is segmented into In Vitro Testing, In Vivo Testing, Computational Toxicology and High-Throughput Screening.
Based on Product, the market is segmented into Reagents & Consumables, Assay Kits and Services.
Based on Assay Type, the market is segmented into Ames Test, Micronucleus Test, Comet Assay and Chromosomal Aberration Test.
Based on End User, the market is segmented into Pharmaceutical Companies, Research Institutions, Contract Research Organizations (CROs) and Government Agencies.
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Genetic Toxicology Testing Market – Regional Analysis:
The global genetic toxicology testing market is analyzed based on its regional presence, which includes North America, Europe, Asia Pacific, Middle East and Africa, and Latin America. The dominant region in the global genetic toxicology testing market is North America.
This region boasts advanced research and development infrastructure, a strong pharmaceutical industry presence, and stringent regulatory frameworks that drive the demand for genetic toxicology testing. The United States, in particular, houses numerous biotechnology and pharmaceutical companies, contributing to the dominant position of North America in this market.
On the other hand, the fastest-growing region in the global genetic toxicology testing market is Asia-Pacific. This region is witnessing a rapid expansion of its pharmaceutical and biotechnology industries, fueled by economic growth, increasing healthcare investments, and a rising focus on drug development.
Top Market Players in Genetic Toxicology Testing Market are:
Thermo Fisher Scientific Inc. (USA)
Charles River Laboratories International, Inc. (USA)
Laboratory Corp of America Holdings (USA)
Eurofins Scientific (Germany)
Jubilant Life Sciences Limited (India)
Merck KGaA (Germany)
Toxikon Corporation (USA)
Gentronix Limited (UK)
WuXi AppTec (China)
Inotiv Inc. (USA)
Creative Bioarray (USA)
MB Research Laboratories (USA)
Molecular Toxicology Inc. (USA)
Toxys (Netherlands)
Syngene International Limited (India)
GeneTox Worldwide Inc. (USA)
Scantox Group (Denmark)
Covance Inc. (USA)
BioReliance Corporation (USA)
Envigo (USA)
For a customized report, contact us to request personalization – https://www.skyquestt.com/speak-with-analyst/genetic-toxicology-testing-market
Genetic Toxicology Testing Market Recent Developments:
In January 2023, the US Environmental Protection Agency (EPA) announced that it would be phasing out the use of certain animal testing methods for genetic toxicology studies. This is a major step towards reducing the use of animals in research and is expected to boost the demand for alternative testing methods, such as genetic toxicology testing.
In February 2023, the European Union (EU) adopted a new regulation on the in vitro testing of chemicals. This regulation will require all new chemicals to be tested for genetic toxicity using in vitro methods. This is expected to create new opportunities for the genetic toxicology testing market in the EU.
In March 2023, a new company called GenTox Health was launched. GenTox Health is a genetic toxicology testing company that uses next-generation sequencing (NGS) technology to provide more accurate and comprehensive testing than traditional methods. This is a new development that is expected to disrupt the genetic toxicology testing market.
Take Action Now: Secure Your Genetic Toxicology Testing Market Today – https://www.skyquestt.com/buy-now/genetic-toxicology-testing-market
Forward-Looking Insights
The Genetic Toxicology Testing Market is set to experience sustained growth, fueled by technological advancements, broader global market access, and rising industry demand. With the industry addressing emerging challenges and capitalizing on new opportunities, it is expected to drive innovation and play a pivotal role in advancing global health and economic progress.
About Company:
SkyQuest is an IP focused Research and Investment Bank and Accelerator of Technology and assets. We provide access to technologies, markets and finance across sectors viz. Life Sciences, CleanTech, AgriTech, NanoTech and Information & Communication Technology.
We work closely with innovators, inventors, innovation seekers, entrepreneurs, companies and investors alike in leveraging external sources of R&D. Moreover, we help them in optimizing the economic potential of their intellectual assets. Our experiences with innovation management and commercialization have expanded our reach across North America, Europe, ASEAN and Asia Pacific.
Contact Details:
SkyQuest Technology Group
USA (+1) 351-333-4748
Email: [email protected]
